These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33528009)

  • 1. Variability in Ceftriaxone Dosing Across 32 US Acute Care Children's Hospitals.
    Ferguson RA; Herigon JC; Lee BR; Nakamura MM; Newland JG
    J Pediatric Infect Dis Soc; 2021 May; 10(5):677-681. PubMed ID: 33528009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Ceftriaxone plus Metronidazole versus Anti-Pseudomonal Antibiotics for Perforated Appendicitis in Children.
    Hamdy RF; Handy LK; Spyridakis E; Dona D; Bryan M; Collins JL; Gerber JS
    Surg Infect (Larchmt); 2019 Jul; 20(5):399-405. PubMed ID: 30874482
    [No Abstract]   [Full Text] [Related]  

  • 3. A pilot study evaluating the prescribing of ceftriaxone in hospitals in Ghana: findings and implications.
    Afriyie DK; Amponsah SK; Dogbey J; Agyekum K; Kesse S; Truter I; Meyer JC; Godman B
    Hosp Pract (1995); 2017 Oct; 45(4):143-149. PubMed ID: 28657382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial.
    Ibrahim LF; Hopper SM; Orsini F; Daley AJ; Babl FE; Bryant PA
    Lancet Infect Dis; 2019 May; 19(5):477-486. PubMed ID: 30853250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriateness of Antibiotic Prescribing in United States Children's Hospitals: A National Point Prevalence Survey.
    Tribble AC; Lee BR; Flett KB; Handy LK; Gerber JS; Hersh AL; Kronman MP; Terrill CM; Sharland M; Newland JG;
    Clin Infect Dis; 2020 Nov; 71(8):e226-e234. PubMed ID: 31942952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibiotic resistance analysis of
    Ge LL; Han ZY; Liu AH; Zhu L; Meng JH
    Zhonghua Er Ke Za Zhi; 2017 Feb; 55(2):109-114. PubMed ID: 28173648
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997.
    Wald ER; Mason EO; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2001 Jan; 20(1):34-9. PubMed ID: 11176564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in ampicillin dosing for lower respiratory tract infections and neonatal bacterial infections in US children's hospitals.
    Daniels EA; McPherson CC; Newland JG; Lee BR
    Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e85. PubMed ID: 36483411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic consumption among hospitalized neonates and children in Punjab province, Pakistan.
    Mustafa ZU; Salman M; Yasir M; Godman B; Majeed HA; Kanwal M; Iqbal M; Riaz MB; Hayat K; Hasan SS
    Expert Rev Anti Infect Ther; 2022 Jun; 20(6):931-939. PubMed ID: 34591720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-based treatment of serious bacterial infections in newborns and young infants: a randomized controlled trial assessing three antibiotic regimens.
    Zaidi AK; Tikmani SS; Warraich HJ; Darmstadt GL; Bhutta ZA; Sultana S; Thaver D
    Pediatr Infect Dis J; 2012 Jul; 31(7):667-72. PubMed ID: 22481421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications for a ceftriaxone dosing regimen in Japanese paediatric patients using population pharmacokinetic/pharmacodynamic analysis and simulation.
    Iida S; Kawanishi T; Hayashi M
    J Pharm Pharmacol; 2011 Jan; 63(1):65-72. PubMed ID: 21155817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying targets for antimicrobial stewardship in children's hospitals.
    Gerber JS; Kronman MP; Ross RK; Hersh AL; Newland JG; Metjian TA; Zaoutis TE
    Infect Control Hosp Epidemiol; 2013 Dec; 34(12):1252-8. PubMed ID: 24225609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Ceftriaxone 80 mg/kg Administration by Rapid Intravenous Infusion-A Clinical Service Evaluation.
    Patel S; Green H; Gray J; Rutter M; Bevan A; Hand K; Jones CE; Faust SN
    Pediatr Infect Dis J; 2021 Feb; 40(2):128-129. PubMed ID: 33165272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THE GLOBAL POINT PREVALENCE SURVEY (PPS) OF ANTIMICROBIAL USE AND ANTIMICROBIAL RESISTANCE AMONG HOSPITALIZED CHILDREN IN GEORGIA.
    Korinteli IG; Mchedlishvili I; Javakhadze M; Versporten A; Goossens H; Phagava H; Pagava K
    Georgian Med News; 2019; (292-293):72-75. PubMed ID: 31560667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors influencing the use of systemic antibiotics in hospitalized pediatric patients in Bucharest, Romania].
    Ion-Nedelcu N; Ulmeanu C; Craciun MD; Popescu I; Vieru F
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(1):47-52. PubMed ID: 20524395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of antibiotic consumption using the "focus of infection" approach in 2 hospitals in Ujjain, India.
    Pathak A; Mahadik K; Dhaneria SP; Sharma A; Eriksson B; Lundborg CS
    PLoS One; 2012; 7(6):e38641. PubMed ID: 22715402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone-related agranulocytosis during outpatient parenteral antibiotic therapy.
    Duncan CJ; Evans TJ; Seaton RA
    J Antimicrob Chemother; 2010 Nov; 65(11):2483-4. PubMed ID: 20810422
    [No Abstract]   [Full Text] [Related]  

  • 18. Ceftriaxone dosing in patients admitted from the emergency department with sepsis.
    Heffernan AJ; Curran RA; Denny KJ; Sime FB; Stanford CL; McWhinney B; Ungerer J; Roberts JA; Lipman J
    Eur J Clin Pharmacol; 2021 Feb; 77(2):207-214. PubMed ID: 32974748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to control antibiotic resistance: results from a survey in Italian children's hospitals.
    Ciofi Degli Atti ML; D'Amore C; Gagliotti C; Zotti C; Ricchizzi E; Moro ML; Raponi M;
    Ann Ig; 2019; 31(1):3-12. PubMed ID: 30554234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
    Ann Intern Med; 1993 Oct; 119(7 Pt 1):584-93. PubMed ID: 8363169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.